tiprankstipranks
Ascendis Pharma (MX:ASND1N)
:ASND1N
Mexico Market

Ascendis Pharma (ASND1N) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ascendis Pharma’s (ASND1N) Moving Averages Convergence Divergence (MACD) indicator is 66.47, suggesting Ascendis Pharma is a Sell.
Ascendis Pharma’s (ASND1N) 20-Day exponential moving average is 4304.14, while Ascendis Pharma’s (ASND1N) share price is $4,270, making it a Buy.
Ascendis Pharma’s (ASND1N) 50-Day exponential moving average is 4187.73, while Ascendis Pharma’s (ASND1N) share price is $4,270, making it a Buy.

Ascendis Pharma (ASND1N) Pivot Points

Sep 08, 2026, 09:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4,218.26
4,321.62
4,373.29
4,476.65
4,528.32
4,631.68
4,683.35
Fibonacci
4,321.62
4,380.84
4,417.43
4,476.65
4,535.87
4,572.46
4,631.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND1N) Moving Averages

Sep 08, 2026, 09:07 AM
Period
Simple
Exponential
MA5
4,393.98Buy
4,394.36Buy
MA10
4,331.99Buy
4,354.73Buy
MA20
4,300.99Buy
4,304.14Buy
MA50
4,143.44Buy
4,187.73Buy
MA100
4,041.34Buy
4,078.58Buy
MA200
3,944.63Buy
3,956.72Buy
Ascendis Pharma’s (ASND1N) 10-Day exponential moving average is 4354.73, while Ascendis Pharma’s (ASND1N) share price is $4,270, making it a Buy.
Ascendis Pharma’s (ASND1N) 100-Day exponential moving average is 4078.58, while Ascendis Pharma’s (ASND1N) share price is $4,270, making it a Buy.
Ascendis Pharma’s (ASND1N) stock price is $4,270 and Ascendis Pharma’s (ASND1N) 50-day simple moving average is 4143.44, creating a Buy signal.
Ascendis Pharma’s (ASND1N) stock price is $4,270 and Ascendis Pharma’s (ASND1N) 100-day simple moving average is 4041.34, creating a Buy signal.
Ascendis Pharma’s (ASND1N) stock price is $4,270 and Ascendis Pharma’s (ASND1N) 200-day simple moving average is 3944.63, creating a Buy signal.

Ascendis Pharma (ASND1N) Technical Indicators

Sep 08, 2026, 09:07 AM
Name
Value
Implied Action
RSI (14)
98.75
Sell
STOCH (9,6)
57.24
Neutral
STOCHRSI (14)
57.24
Neutral
MACD (12,26)
66.47
Sell
ADX (14)
86.65
Sell
Williams %R
-46.36
Buy
CCI (14)
211.83
Sell
ATR (14)
197.51
-
Ultimate Oscillator
15.20
Sell
ROC
3.63
Buy
Ascendis Pharma’s (ASND1N) Relative Strength Index (RSI) is 98.75, creating a Sell signal.
Ascendis Pharma’s (ASND1N) Trend Strength Indicator (ADX) is 86.65, creating a Sell signal.
Ascendis Pharma’s (ASND1N) Commodity Channel Index (CCI) is 211.83, creating a Sell signal.
Ascendis Pharma’s (ASND1N) Price Rate of Change (ROC) is 3.63, creating a Buy signal.

FAQ

Is ASND1N a Buy, Hold, or Sell?
Based on ASND1N’s technical indicators, ASND1N is a Buy.
    What is ASND1N’s RSI (14)?
    ASND1N’s RSI (14) is 98.75, which suggests ASND1N is a Sell.
      What is ASND1N’s MACD?
      ASND1N’s MACD is 66.47, which suggests ASND1N is a Sell.
        What is ASND1N’s 5-day moving average?
        ASND1N’s 5-day moving average is 4393.98, which suggests ASND1N is a Buy.
          What is ASND1N’s 20-day moving average?
          ASND1N 20-day moving average is 4300.99, which suggests ASND1N is a Buy.
            What is ASND1N’s 50-day moving average?
            ASND1N’s 50-day moving average is 4143.44, which suggests ASND1N is a Buy.
              What is ASND1N’s 200-day moving average?
              ASND1N’s 200-day moving average is 3944.63, which suggests ASND1N is a Buy.
                What is ASND1N’s Williams % R (14)?
                ASND1N’s Williams % R (14) is -46.36, which suggests ASND1N is a Buy.
                  What is ASND1N’s CCI (14)?
                  ASND1N’s CCI (14) is 211.83, which suggests ASND1N is a Sell.
                    What is the share price of Ascendis Pharma?